|
by Butler, Mary
Published 2018
“... to placebo (low-strength evidence). However, improvements were of modest clinical significance, with values...”Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Butler, Mary
Published 2018
“... to placebo (low-strength evidence). However, improvements were of modest clinical significance, with values...”Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Butler, Mary, Forte, Mary, Braman, Jon, Swiontkowski, Marc F.
Published 2013
Published 2013
Agency for Healthcare Research and Quality
|
by Butler, Mary, Forte, Mary, Braman, Jon, Swiontkowski, Marc F.
Published 2013
Published 2013
Agency for Healthcare Research and Quality
|
by Fink, Howard A.
Published 2019
Published 2019
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Fink, Howard A.
Published 2019
Published 2019
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Shamliyan, Tatyana, Kane, Robert L., Taylor, Frederick R.
Published 2013
“... to topiramate monotherapy (low-strength evidence from one RCT of 191 adults). For episodic migraine, RCTs...”Published 2013
Department of Health & Human Services, Agency for Healthcare Research and Quality
|
by Shamliyan, Tatyana, Kane, Robert L., Taylor, Frederick R.
Published 2013
“... to topiramate monotherapy (low-strength evidence from one RCT of 191 adults). For episodic migraine, RCTs...”Published 2013
Department of Health & Human Services, Agency for Healthcare Research and Quality
|
by Wilt, Timothy J.
Published 2012
Published 2012
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Wilt, Timothy J.
Published 2012
Published 2012
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services